Literature DB >> 12122205

The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans.

James F Morley1, Heather R Brignull, Jill J Weyers, Richard I Morimoto.   

Abstract

Studies of the mutant gene in Huntington's disease, and for eight related neurodegenerative disorders, have identified polyglutamine (polyQ) expansions as a basis for cellular toxicity. This finding has led to a disease hypothesis that protein aggregation and cellular dysfunction can occur at a threshold of approximately 40 glutamine residues. Here, we test this hypothesis by expression of fluorescently tagged polyQ proteins (Q29, Q33, Q35, Q40, and Q44) in the body wall muscle cells of Caenorhabditis elegans and show that young adults exhibit a sharp boundary at 35-40 glutamines associated with the appearance of protein aggregates and loss of motility. Surprisingly, genetically identical animals expressing near-threshold polyQ repeats exhibited a high degree of variation in the appearance of protein aggregates and cellular toxicity that was dependent on repeat length and exacerbated during aging. The role of genetically determined aging pathways in the progression of age-dependent polyQ-mediated aggregation and cellular toxicity was tested by expressing Q82 in the background of age-1 mutant animals that exhibit an extended lifespan. We observed a dramatic delay of polyQ toxicity and appearance of protein aggregates. These data provide experimental support for the threshold hypothesis of polyQ-mediated toxicity in an experimental organism and emphasize the importance of the threshold as a point at which genetic modifiers and aging influence biochemical environment and protein homeostasis in the cell.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12122205      PMCID: PMC124929          DOI: 10.1073/pnas.152161099

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

Review 1.  Protein fate in neurodegenerative proteinopathies: polyglutamine diseases join the (mis)fold.

Authors:  H L Paulson
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

2.  Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology.

Authors:  E Scherzinger; A Sittler; K Schweiger; V Heiser; R Lurz; R Hasenbank; G P Bates; H Lehrach; E E Wanker
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

Review 3.  Glutamine repeats and neurodegenerative diseases: molecular aspects.

Authors:  M F Perutz
Journal:  Trends Biochem Sci       Date:  1999-02       Impact factor: 13.807

4.  Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila.

Authors:  J L Marsh; H Walker; H Theisen; Y Z Zhu; T Fielder; J Purcell; L M Thompson
Journal:  Hum Mol Genet       Date:  2000-01-01       Impact factor: 6.150

5.  Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70.

Authors:  J M Warrick; H Y Chan; G L Gray-Board; Y Chai; H L Paulson; N M Bonini
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

6.  Ingestion of bacterially expressed dsRNAs can produce specific and potent genetic interference in Caenorhabditis elegans.

Authors:  L Timmons; D L Court; A Fire
Journal:  Gene       Date:  2001-01-24       Impact factor: 3.688

7.  Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse.

Authors:  J M Ordway; S Tallaksen-Greene; C A Gutekunst; E M Bernstein; J A Cearley; H W Wiener; L S Dure; R Lindsey; S M Hersch; R S Jope; R L Albin; P J Detloff
Journal:  Cell       Date:  1997-12-12       Impact factor: 41.582

8.  Expanded polyglutamine domain proteins bind neurofilament and alter the neurofilament network.

Authors:  Y Nagai; O Onodera; J Chun; W J Strittmatter; J R Burke
Journal:  Exp Neurol       Date:  1999-02       Impact factor: 5.330

9.  Identification of genes that modify ataxin-1-induced neurodegeneration.

Authors:  P Fernandez-Funez; M L Nino-Rosales; B de Gouyon; W C She; J M Luchak; P Martinez; E Turiegano; J Benito; M Capovilla; P J Skinner; A McCall; I Canal; H T Orr; H Y Zoghbi; J Botas
Journal:  Nature       Date:  2000-11-02       Impact factor: 49.962

10.  Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron.

Authors:  P W Faber; J R Alter; M E MacDonald; A C Hart
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

View more
  368 in total

1.  Glutamine/proline-rich PQE-1 proteins protect Caenorhabditis elegans neurons from huntingtin polyglutamine neurotoxicity.

Authors:  Peter W Faber; Cindy Voisine; Daphne C King; Emily A Bates; Anne C Hart
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-16       Impact factor: 11.205

2.  Dynamic imaging by fluorescence correlation spectroscopy identifies diverse populations of polyglutamine oligomers formed in vivo.

Authors:  Monica Beam; M Catarina Silva; Richard I Morimoto
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

3.  20S proteasome activation promotes life span extension and resistance to proteotoxicity in Caenorhabditis elegans.

Authors:  Niki Chondrogianni; Konstantina Georgila; Nikos Kourtis; Nektarios Tavernarakis; Efstathios S Gonos
Journal:  FASEB J       Date:  2014-11-13       Impact factor: 5.191

4.  A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila.

Authors:  Barbara L Apostol; Alexsey Kazantsev; Simona Raffioni; Katalin Illes; Judit Pallos; Laszlo Bodai; Natalia Slepko; James E Bear; Frank B Gertler; Steven Hersch; David E Housman; J Lawrence Marsh; Leslie Michels Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-01       Impact factor: 11.205

Review 5.  Polyglutamine misfolding in yeast: toxic and protective aggregation.

Authors:  Martin L Duennwald
Journal:  Prion       Date:  2011-10-01       Impact factor: 3.931

Review 6.  Genetics, life span, health span, and the aging process in Caenorhabditis elegans.

Authors:  Heidi A Tissenbaum
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-04-12       Impact factor: 6.053

7.  Complete suppression of Htt fibrilization and disaggregation of Htt fibrils by a trimeric chaperone complex.

Authors:  Annika Scior; Alexander Buntru; Kristin Arnsburg; Anne Ast; Manuel Iburg; Katrin Juenemann; Maria Lucia Pigazzini; Barbara Mlody; Dmytro Puchkov; Josef Priller; Erich E Wanker; Alessandro Prigione; Janine Kirstein
Journal:  EMBO J       Date:  2017-12-06       Impact factor: 11.598

Review 8.  Challenging Proteostasis: Role of the Chaperone Network to Control Aggregation-Prone Proteins in Human Disease.

Authors:  Tessa Sinnige; Anan Yu; Richard I Morimoto
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

9.  Sex-dependent resistance to the pathogenic fungus Cryptococcus neoformans.

Authors:  Maaike C W van den Berg; Jessica Z Woerlee; Hansong Ma; Robin C May
Journal:  Genetics       Date:  2006-04-02       Impact factor: 4.562

10.  Genetic evidence linking age-dependent attenuation of the 26S proteasome with the aging process.

Authors:  Ayako Tonoki; Erina Kuranaga; Takeyasu Tomioka; Jun Hamazaki; Shigeo Murata; Keiji Tanaka; Masayuki Miura
Journal:  Mol Cell Biol       Date:  2008-12-15       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.